-
ASMI Media Releases – New PSA President
ASMI congratulates new PSA National President 17 June 2015 – The Australian Self Medication Industry (ASMI) today congratulated Joe Demarte on his appointment as the new National President of the Pharmaceutical Society of Australia (PSA). ASMI Executive Director, Deon Schoombie, welcomed Mr Demarte and thanked outgoing President Grant Kardachi for his strong leadership of the…
-
ASMI Media Release – ASMI supports real-time monitoring of OTC codeine containing analgesics
ASMI supports real-time monitoring of OTC codeine containing analgesics 15 May 2015 – The Australian Self Medication Industry (ASMI) today supported calls by the Pharmacy Guild of Australia and the Pharmaceutical Society of Australia for a national real-time monitoring system for over-the-counter (OTC) codeine containing analgesics. Dr Deon Schoombie, ASMI Executive Director, said ASMI’s submission…
-
ASMI Media Release – ASMI welcomes Vic. Prescription Monitoring
ASMI welcomes Victorian Government funding for real-time prescription monitoring system 6 May 2015 – The Australian Self Medication Industry (ASMI) today welcomed the Victorian Government’s commitment of $300,000 for planning and development of a real-time prescription monitoring system to help reduce the inappropriate use of some medicines. Dr Deon Schoombie, ASMI Executive Director, said: “A…
-
ASMI Media Release – 1. Call for better rather than less regulation of complementary medicines
ASMI calls on Federal Government for better rather than less regulation of complementary medicines 20 April 2015 – The Australian Self Medication Industry today urged the Federal Government to fine tune the regulatory system for complementary medicines, calling for better rather than less regulation of complementary medicines. Dr Deon Schoombie, ASMI Executive Director, said ASMI’s…
-
ASMI Media Release – New Fish Oil Study
New study reinforces importance of dietary fish oils for cardiovascular health 13 April 2015 – The Australian Self Medication Industry (ASMI) today said new research reinforces the importance of dietary fish oils for cardiovascular health. This was in response to a recently published review by the National Heart Foundation of Australia of studies of omega-3…
-
ASMI Media Releases – New Study Supports Fish Oil Supplementation
New study reinforces importance of dietary fish oils for cardiovascular health 13 April 2015 – The Australian Self Medication Industry (ASMI) today said new research reinforces the importance of dietary fish oils for cardiovascular health. This was in response to a recently published review by the National Heart Foundation of Australia of studies of omega-3…
-
ASMI Media Release – 1. Zinc lozenges reduce duration of common cold 2. Australia lags NZ in “switches”
New study found zinc lozenges reduce duration of common cold 19 March 2015 – The Australian Self Medication Industry (ASMI) welcomed a new study, which revealed that high dose zinc acetate lozenges reduce the duration of the common cold. The study, a meta-analysis of three placebo-controlled, randomised, double blind studies, was published in the journal,…
-
ASMI Media Releases – 1. Self Care Drives Pharmacy Growth 2. Calcium reduces osteoporosis risk
Increasing consumer self care is a key driver of pharmacy growth 12 March 2015 – Increasing consumer self care is a key driver of pharmacy growth, said Mark Sargent, President of the Australian Self Medication Industry (ASMI), at APP 2015. “More down-scheduling from prescription (Rx) to over-the-counter (OTC) medicines and removal of S3 consumer communication…
-
ASMI Media Releases – 1. Paracetamol Use 2. Intergenerational Report & Self Care
OTC paracetamol is for short term use 4 March 2015 – The Australian Self Medication Industry (ASMI) confirmed that over-the-counter (OTC) paracetamol is for short term use and has a well-known safety profile, when taken at the recommended dose. ASMI Regulatory and Scientific Affairs Director Steve Scarff said: “Worldwide, paracetamol has a long history of…
-
ASMI Media Releases 1.New research confirms benefits of chondroitin for osteoarthritis 2. ASMI welcomes complementary meds review
New research confirms benefits of chondroitin for osteoarthritis 27 February 2015 – The Australian Self Medication Industry (ASMI) today welcomed new research that confirmed the benefits of chondroitin sulphate for osteoarthritis. A Cochrane Review of 9,110 people across 43 randomised controlled studies revealed that chondroitin sulphate (alone or in combination with glucosamine) was better than…